Subtopic Deep Dive
Tropheryma whipplei Pathogenesis
Research Guide
What is Tropheryma whipplei Pathogenesis?
Tropheryma whipplei pathogenesis refers to the molecular mechanisms by which T. whipplei invades host cells, evades immune responses, and causes Whipple's disease through dysregulated Th1/Th2 immunity and gastrointestinal manifestations.
T. whipplei, identified as the causative agent in 2000, leads to chronic infection with protean symptoms including diarrhea, weight loss, and arthralgia (Fenollar et al., 2007, 624 citations). Key papers highlight immune dysregulation, with immunosuppressive therapy triggering gastrointestinal onset (Mahnel et al., 2005, 137 citations) and altered Th1/Th2 responses at mucosal sites (Marth et al., 2002, 111 citations). Over 10 major reviews from 2002-2017 detail host-pathogen interactions, with Schneider et al. (2008, 361 citations) updating pathogenesis models.
Why It Matters
Understanding T. whipplei pathogenesis enables targeted antibiotics over broad-spectrum use, reducing relapse in Whipple's disease patients (Fenollar et al., 2007). Schneider et al. (2008) link immune evasion to treatment failures, informing TNF inhibitor warnings after unmasking cases (Marth, 2015, 92 citations). Moos and Schneider (2011, 90 citations) reveal asymptomatic carriage, guiding screening in pneumonia and arthritis (Bousbia et al., 2010, 105 citations), while Dolmans et al. (2017, 215 citations) stress PCR diagnosis for extraintestinal forms.
Key Research Challenges
Immune Evasion Mechanisms
T. whipplei persists intracellularly despite antibiotics, linked to poor immune cell killing (Schneider et al., 2008). Dysregulated Th1/Th2 responses fail to clear infection (Marth et al., 2002). No virulence factors fully identified (Fenollar et al., 2007).
Asymptomatic Carriage Detection
Many harbor T. whipplei without disease, complicating pathogenesis models (Moos and Schneider, 2011). PCR detects it in pneumonia without Whipple's (Bousbia et al., 2010). Triggers for progression unclear (Marth et al., 2016).
Immunosuppression Interactions
TNF inhibitors unmask Whipple's by altering immunity (Marth, 2015). Therapy induces diarrhea in carriers (Mahnel et al., 2005). Host factors determining progression undefined (Dolmans et al., 2017).
Essential Papers
Whipple's Disease
Florence Fenollar, Xavier Puéchal, Didier Raoult · 2007 · New England Journal of Medicine · 624 citations
In 2000, Tropheryma whipplei was finally identified as the cause of Whipple's disease, a chronic condition with protean manifestations that was first described in 1907. This review discusses the ep...
Whipple's disease: new aspects of pathogenesis and treatment
Thomas Schneider, Verena Moos, Christoph Loddenkemper et al. · 2008 · The Lancet Infectious Diseases · 361 citations
Clinical Manifestations, Treatment, and Diagnosis of Tropheryma whipplei Infections
Ruben A. V. Dolmans, C. H. E. Boel, Miangela M. Laclé et al. · 2017 · Clinical Microbiology Reviews · 215 citations
SUMMARY Whipple's disease is a rare infectious disease that can be fatal if left untreated. The disease is caused by infection with Tropheryma whipplei , a bacterium that may be more common than wa...
Tropheryma whipplei infection and Whipple's disease
Thomas Marth, Verena Moos, Christian Müller et al. · 2016 · The Lancet Infectious Diseases · 209 citations
Immunosuppressive Therapy in Whipple's Disease Patients is Associated with the Appearance of Gastrointestinal Manifestations
R. Mahnel, Anja Kalt, Sabine Ring et al. · 2005 · The American Journal of Gastroenterology · 137 citations
These results indicate an association between immunosuppressive therapy and the onset of diarrhea in Whipple's disease and thus support the concept that immunologic factors play a role in disease p...
Diagnosis of Whipple Disease by Immunohistochemical Analysis
Blaire L. Baisden, Hubert Lépidi, Didier Raoult et al. · 2002 · American Journal of Clinical Pathology · 112 citations
Whipple disease is a rare infection characterized clinically by diarrhea, fever, weight loss, arthralgia, malabsorption, and other systemic manifestations. The etiologic agent, Tropheryma whipplei,...
Dysregulated peripheral and mucosal Th1/Th2 response in Whipple's disease
Thomas Marth, Nicole Kleen, Andreas Stallmach et al. · 2002 · Gastroenterology · 111 citations
Reading Guide
Foundational Papers
Start with Fenollar et al. (2007, 624 citations) for core epidemiology/pathogenesis overview, then Schneider et al. (2008, 361 citations) for immune mechanisms, and Mahnel et al. (2005, 137 citations) for immunosuppression links.
Recent Advances
Study Dolmans et al. (2017, 215 citations) for updated diagnostics/manifestations, Marth et al. (2016, 209 citations) for infection review, and Marth (2015, 92 citations) for TNF inhibitor risks.
Core Methods
PCR for detection (Bousbia et al., 2010); immunohistochemistry (Baisden et al., 2002); Th1/Th2 cytokine profiling and flow cytometry (Marth et al., 2002).
How PapersFlow Helps You Research Tropheryma whipplei Pathogenesis
Discover & Search
PapersFlow's Research Agent uses searchPapers on 'Tropheryma whipplei immune evasion' to retrieve Fenollar et al. (2007), then citationGraph maps 624 citing works by Schneider (2008) and Marth (2016), while findSimilarPapers expands to Th1/Th2 dysregulation papers and exaSearch uncovers rare pneumonia cases from Bousbia et al. (2010).
Analyze & Verify
Analysis Agent applies readPaperContent to Schneider et al. (2008) for pathogenesis excerpts, verifyResponse with CoVe cross-checks claims against Marth et al. (2002) Th1/Th2 data, and runPythonAnalysis plots citation trends from 10 papers using pandas, with GRADE grading assigning high evidence to Fenollar et al. (2007) reviews.
Synthesize & Write
Synthesis Agent detects gaps in virulence factor studies across Fenollar (2007) and Moos (2011), flags contradictions in immunosuppression effects (Mahnel 2005 vs. Marth 2015), while Writing Agent uses latexEditText for methods sections, latexSyncCitations for 20+ refs, latexCompile for full reports, and exportMermaid diagrams host-pathogen interactions.
Use Cases
"Extract Th1/Th2 data from Whipple's papers and plot dysregulation trends"
Research Agent → searchPapers 'Th1 Th2 Whipple' → Analysis Agent → readPaperContent (Marth 2002) → runPythonAnalysis (pandas plot ratios) → matplotlib figure of immune imbalance.
"Draft LaTeX review on T. whipplei pathogenesis with citations"
Synthesis Agent → gap detection (Fenollar 2007, Schneider 2008) → Writing Agent → latexEditText (pathogenesis section) → latexSyncCitations (10 papers) → latexCompile → PDF export.
"Find code analyzing T. whipplei genomes from papers"
Research Agent → searchPapers 'Tropheryma whipplei genome' → Code Discovery → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → Python scripts for virulence gene analysis.
Automated Workflows
Deep Research workflow runs systematic review on 'Tropheryma whipplei pathogenesis', chaining searchPapers (50+ papers) → citationGraph → GRADE grading for structured report on immune evasion. DeepScan applies 7-step analysis to Marth et al. (2016), with CoVe checkpoints verifying claims against Fenollar (2007). Theorizer generates hypotheses on Th1/Th2 triggers from Mahnel (2005) and Moos (2011).
Frequently Asked Questions
What defines Tropheryma whipplei pathogenesis?
Molecular processes of T. whipplei host invasion, immune evasion via Th1/Th2 dysregulation, and progression to Whipple's symptoms (Fenollar et al., 2007; Marth et al., 2002).
What methods study it?
PCR detection, immunohistochemistry (Baisden et al., 2002), and immunological assays for Th1/Th2 cytokines (Marth et al., 2002; Schneider et al., 2008).
What are key papers?
Fenollar et al. (2007, 624 citations) reviews epidemiology/pathogenesis; Schneider et al. (2008, 361 citations) details new aspects; Dolmans et al. (2017, 215 citations) covers manifestations.
What open problems exist?
Virulence factors unidentified; triggers from carriage to disease unclear; immunosuppression interactions need models (Moos and Schneider, 2011; Marth, 2015).
Research Whipple's Disease and Interleukins with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Tropheryma whipplei Pathogenesis with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers